Anthrax in America 2001-2003JOSHI, Shivang G; CYMET, Holly Berkovits; KERKVLIET, Gary et al.Journal of the National Medical Association. 2004, Vol 96, Num 3, pp 344-350, issn 0027-9684, 7 p.Article

Poisoned food, Poisoned uniforms, and Anthrax: Or, how Guerillas die in warWHITE, Luise.Osiris (Philadelphia, PA). 2004, Vol 19, pp 220-233, issn 0369-7827, 14 p.Article

Statistical analysis of bacterial spore aerosols created by opening a spore containing anthrax letter in an officeKOURNIKAKIS, Bill; WALKER, Mike; HO, Jim et al.Journal of aerosol science. 2009, Vol 40, Num 6, pp 514-522, issn 0021-8502, 9 p.Article

Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteersHOPKINS, Robert J; DACZKOWSKI, Nancy F; KAPTUR, Paulina E et al.Vaccine. 2013, Vol 31, Num 30, pp 3051-3058, issn 0264-410X, 8 p.Article

Characterisation of adsorbed anthrax vaccine by two-dimensional gel electrophoresisWHITING, G. C; RIJPKEMA, S; ADAMS, T et al.Vaccine. 2004, Vol 22, Num 31-32, pp 4245-4251, issn 0264-410X, 7 p.Article

Anthrax vaccination induced anti-lethal factor IgG: Fine specificity and neutralizing capacityCROWE, Sherry R; GARMAN, Lori; ENGLER, Renata J. M et al.Vaccine. 2011, Vol 29, Num 20, pp 3670-3678, issn 0264-410X, 9 p.Article

Estimating aerosol hazards from an anthrax letterHO, J; DUNCAN, S.Journal of aerosol science. 2005, Vol 36, Num 5-6, pp 701-719, issn 0021-8502, 19 p.Article

Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigenDUC, Le H; HONG, Huynh A; ATKINS, Helen S et al.Vaccine. 2007, Vol 25, Num 2, pp 346-355, issn 0264-410X, 10 p.Article

Anthrax: altbekannt und hochaktuell: Hautmilzbrand am Auge = Anthrax: an old disease becomes topical: cutaneous anthrax and the eyeKALPADAKIS, P; RUDOLPH, G; STEFANI, F. H et al.Der Ophthalmologe (Berlin. Print). 2003, Vol 100, Num 3, pp 216-221, issn 0941-293X, 6 p.Article

Two Cases of Gastrointestinal Anthrax with an Unusual Presentation from Kermanshah (Western Iran)HATAMI, Hossein; RAMAZANKHANI, Ali; MANSOORI, Feizollah et al.Archives of Iranian medicine. 2010, Vol 13, Num 2, pp 156-159, 4 p.Article

Proteolytic assay-based screening identifies a potent inhibitor of anthrax lethal factorPARK, Hae-Chul; SUNG, So-Ra; SU MIN LIM et al.Microbial pathogenesis. 2012, Vol 53, Num 2, pp 109-112, issn 0882-4010, 4 p.Article

Efficient methods for large-area surface sampling of sites contaminated with pathogenic microorganisms and other hazardous agents: current state, needs, and perspectivesEDMONDS, Jason M.Applied microbiology and biotechnology. 2009, Vol 84, Num 5, pp 811-816, issn 0175-7598, 6 p.Article

Immunogenicity of a subunit vaccine against Bacillus anthracisCHICHESTER, Jessica A; MUSIYCHUK, Konstantin; DE LA ROSA, Patricia et al.Vaccine. 2007, Vol 25, Num 16, pp 3111-3114, issn 0264-410X, 4 p.Conference Paper

An immuno-diffusion assay to assess the protective antigen content of anthrax vaccineADAMS, Trudy; OSBOM, Sancha; RIJPKEMA, Sjoerd et al.Vaccine. 2005, Vol 23, Num 36, pp 4517-4520, issn 0264-410X, 4 p.Article

Potentiation of an anthrax DNA vaccine with electroporationLUXEMBOURG, A; HANNAMAN, D; NOLAN, E et al.Vaccine. 2008, Vol 26, Num 40, pp 5216-5222, issn 0264-410X, 7 p.Conference Paper

Biological agents with potential for misuse: a historical perspective and defensive measuresBHALLA, Deepak K; WARHEIT, David B.Toxicology and applied pharmacology. 2004, Vol 199, Num 1, pp 71-84, issn 0041-008X, 14 p.Article

Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adultsBERNSTEIN, David I; JACKSON, Lisa; PATEL, Shital M et al.Vaccine. 2014, Vol 32, Num 47, pp 6284-6293, issn 0264-410X, 10 p.Article

Anthrax sub-unit vaccine: The structural consequences of binding rPA83 to Alhydrogel^®SOLIAKOV, Andrei; KELLY, Ian F; LAKEY, Jeremy H et al.European journal of pharmaceutics and biopharmaceutics. 2012, Vol 80, Num 1, pp 25-32, issn 0939-6411, 8 p.Article

Anthrax capsule vaccine protects against experimental infectionCHABOT, Donald J; SCORPIO, Angelo; TOBERY, Steven A et al.Vaccine. 2004, Vol 23, Num 1, pp 43-47, issn 0264-410X, 5 p.Article

Risk analysis of an anthrax outbreak in cattle and humans of Sesheke district of Western ZambiaMWEEMBA MUNANG'ANDU, Hetron; BANDA, Fredrick; CHIKAMPA, Webster et al.Acta tropica. 2012, Vol 124, Num 2, pp 162-165, issn 0001-706X, 4 p.Article

Advances in the development of next-generation anthrax vaccinesFRIEDLANDER, Arthur M; LITTLE, Stephen F.Vaccine. Supplement. 2009, Vol 27, Num 4, issn 1359-5938, D28-D32Article

Evaluation of Bacillus anthracis extractable antigen for testing anthrax immunitySHLYAKHOV, E; SHOENFELD, Y; GILBURD, B et al.Clinical microbiology and infection. 2004, Vol 10, Num 5, pp 421-424, issn 1198-743X, 4 p.Article

The history of anthraxSTERNBACH, George.The Journal of emergency medicine. 2003, Vol 24, Num 4, pp 463-467, issn 0736-4679, 5 p.Article

Increased potency of BioThrax® anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109MILI GU; HINE, Paul M; JACKSON, W. James et al.Vaccine. 2007, Vol 25, Num 3, pp 526-534, issn 0264-410X, 9 p.Article

Systemic but not mucosal immunity induced by AVA prevents inhalational anthraxKLINMAN, Dennis M; CURRIE, Debra; LEE, Gloria et al.Microbes and infection. 2007, Vol 9, Num 12-13, pp 1478-1483, issn 1286-4579, 6 p.Article